Atlas Trials

Singlera Genomics Inc.

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Singlera Genomics Inc.

RecordFirmDate
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial (NCT06842563)Singlera Genomics Inc.2025-02-25
INSPIRE: a Multi-Cancer Early Detection Study (NCT06440018)Singlera Genomics Inc.2024-07-20
Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular Carcinoma (NCT06178809)Singlera Genomics Inc.2023-12-25
Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer (NCT05858242)Singlera Genomics Inc.2023-03-07
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma (NCT05626985)Singlera Genomics Inc.2022-10-19
ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation (NCT05536089)Singlera Genomics Inc.2022-09-05
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection (NCT06895551)Singlera Genomics Inc.2022-09-01
A Prospective Cohort Study on Colorectal Cancer Screening in Community Population (NCT05485077)Singlera Genomics Inc.2022-07-09
Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer (NCT05444491)Singlera Genomics Inc.2022-06-20
A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou (NCT05336539)Singlera Genomics Inc.2022-04-01
Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer (NCT05336058)Singlera Genomics Inc.2022-02-01
The FuSion Program: A Prospective and Multicenter Cohort Study of Pan-Cancer Screening in Chinese Population (NCT05159544)Singlera Genomics Inc.2021-07-06
Clinical Validation of ColonAiQ (a Blood-based Assay Targeting ctDNA Methylation) for Colorectal Cancer Detection (NCT06347887)Singlera Genomics Inc.2021-05-31
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer (NCT05432128)Singlera Genomics Inc.2020-01-01

Track Singlera Genomics Inc. automatically

Every clearance here is in the API, with alerts when new ones post.